Neon Health launches with $6M in funding to solve the prescription abandonment crisis
Neon Health launches with $6M in funding to solve the prescription abandonment crisis
Tuesday, September 2, 2025
Tuesday, September 2, 2025
Neon Health, a startup building AI agents to automate patient access workflows, today announced a $6 million seed round led by NFX, with participation from DigiTx, Olive Capital, Ascend, Village Global, Digital Health Venture Partners, and other strategic healthcare investors.
Neon Health, a startup building AI agents to automate patient access workflows, today announced a $6 million seed round led by NFX, with participation from DigiTx, Olive Capital, Ascend, Village Global, Digital Health Venture Partners, and other strategic healthcare investors.
Solving access barriers with AI agents
Each year, over half of specialty medication prescriptions are abandoned. These are not routine medications—specialty drugs treat conditions like Crohn’s disease, cancer, and autoimmune disorders. Patients often delay or forgo treatment entirely because of cost barriers, insurance hurdles, and administrative delays, leading to unnecessary suffering, ER visits, and even preventable deaths. Neon Health is tackling this crisis head-on by building an AI workforce that eliminates the bottlenecks between prescription and treatment.
Each year, over half of specialty medication prescriptions are abandoned. These are not routine medications—specialty drugs treat conditions like Crohn’s disease, cancer, and autoimmune disorders. Patients often delay or forgo treatment entirely because of cost barriers, insurance hurdles, and administrative delays, leading to unnecessary suffering, ER visits, and even preventable deaths. Neon Health is tackling this crisis head-on by building an AI workforce that eliminates the bottlenecks between prescription and treatment.
Rapid traction and measurable ROI
Neon Health’s AI workers (“agents”) automate the most time-consuming workflows in patient access:
Benefits verification
Prior authorization
Financial assistance enrollment
Patient onboarding & inquiries
Care coordination
Adherence support
“Patients battling cancer or autoimmune conditions shouldn’t have to wait weeks because insurance is fighting with their doctor,” said Stedman Hood, Co-Founder and CEO of Neon Health. “We built Neon to ensure access to medicine is determined by clinical need – not bureaucracy or financial barriers. This funding enables us to scale our AI workforce so patients can start life-saving treatments faster.”
Neon Health’s AI workers (“agents”) automate the most time-consuming workflows in patient access:
Benefits verification
Prior authorization
Financial assistance enrollment
Patient onboarding & inquiries
Care coordination
Adherence support
“Patients battling cancer or autoimmune conditions shouldn’t have to wait weeks because insurance is fighting with their doctor,” said Stedman Hood, Co-Founder and CEO of Neon Health. “We built Neon to ensure access to medicine is determined by clinical need – not bureaucracy or financial barriers. This funding enables us to scale our AI workforce so patients can start life-saving treatments faster.”
Building the future of enterprise SaaS
Neon Health has already achieved significant early traction. Its first customer engagement produced a 300% ROI in just two months, and the company is now scaling fast with seven-figure enterprise deals.
Unlike plug-and-play SaaS tools, Neon takes a consultative, integration-first approach – embedding directly into large healthcare enterprises to deliver customized solutions. This model, similar to Palantir’s, enables rapid deployment, deeper customer retention, and measurable financial impact.
“Neon is tackling one of healthcare’s most painful bottlenecks with an approach that combines cutting-edge AI and deep enterprise integration,” said James Currier, General Partner at NFX. “Their early results show the potential not just to fix prescription abandonment, but to reshape how healthcare organizations leverage AI to unlock access to care.”
Neon Health has already achieved significant early traction. Its first customer engagement produced a 300% ROI in just two months, and the company is now scaling fast with seven-figure enterprise deals.
Unlike plug-and-play SaaS tools, Neon takes a consultative, integration-first approach – embedding directly into large healthcare enterprises to deliver customized solutions. This model, similar to Palantir’s, enables rapid deployment, deeper customer retention, and measurable financial impact.
“Neon is tackling one of healthcare’s most painful bottlenecks with an approach that combines cutting-edge AI and deep enterprise integration,” said James Currier, General Partner at NFX. “Their early results show the potential not just to fix prescription abandonment, but to reshape how healthcare organizations leverage AI to unlock access to care.”
About Neon Health
Neon’s business model reflects a broader thesis on the future of enterprise software: that the next generation of solutions will be custom-built by AI agents, rather than bought off-the-shelf.
By deeply embedding into healthcare workflows today, Neon is positioning itself as the “trusted AI partner” for enterprises seeking bespoke automation at scale. Its modular platform allows customers to “hot swap” new AI capabilities as the technology evolves, ensuring long-term resilience and competitive advantage.
Neon’s business model reflects a broader thesis on the future of enterprise software: that the next generation of solutions will be custom-built by AI agents, rather than bought off-the-shelf.
By deeply embedding into healthcare workflows today, Neon is positioning itself as the “trusted AI partner” for enterprises seeking bespoke automation at scale. Its modular platform allows customers to “hot swap” new AI capabilities as the technology evolves, ensuring long-term resilience and competitive advantage.
Neon Health is an AI automation company on a mission to solve the prescription abandonment crisis. By deploying AI agents that automate critical patient access workflows, Neon helps healthcare enterprises ensure that patients receive life-saving medications without delay. Founded in 2024, Neon Health is headquartered in San Francisco.
For more information, visit www.neonhealth.com.
Media Contact: press@neonhealth.com
Neon Health is an AI automation company on a mission to solve the prescription abandonment crisis. By deploying AI agents that automate critical patient access workflows, Neon helps healthcare enterprises ensure that patients receive life-saving medications without delay. Founded in 2024, Neon Health is headquartered in San Francisco.
For more information, visit www.neonhealth.com.
Media Contact: press@neonhealth.com
Related articles
Related articles
Ready to transform Patient Access?
Ready to transform Patient Access?
Experience firsthand how Neon can streamline your patient access operations and dramatically enhance your bottom line.
Experience firsthand how Neon can streamline your patient access operations and dramatically enhance your bottom line.
NEWSLETTER
@ 2025 Neon Health (Belay, Inc).
AI-powered patient access automation
for leading pharma enterprises.
NEWSLETTER
@ 2025 Neon Health (Belay, Inc).
AI-powered patient access automation for leading pharma enterprises.
NEWSLETTER
@ 2025 Neon Health (Belay, Inc).
AI-powered patient access automation
for leading pharma enterprises.